DrugPatentWatch Database Preview

Details for Patent: 8,048,035

Which drugs does patent 8,048,035 protect, and when does it expire?

Patent 8,048,035 protects EPIPEN and EPIPEN JR. and is included in one NDA.

This patent has thirty patent family members in seventeen countries.

Summary for Patent: 8,048,035

Title:	Automatic injector with needle cover
Abstract:	An auto-injector automatically dispenses a predetermined dose of medicament upon activation. The auto-injector includes a needle cover operative to engage an injection site and activate the injector. The needle cover is configured to move from a locked retracted position prior to a medicament dispensing operation to a locked extended position after the medicament dispensing operation. The non-removable needle cover prevents contact with the needle both before and after the medicament dispensing operation.
Inventor(s):	Mesa; C. Michael (Boyds, MD), Cors; Sarah Jane (Reston, VA), Penney; Melinda Fischer (Providence, RI), Tomellini; Dalita Rosemarie (Rehoboth, MA), Bremley; Mark Bumb (Edwardsville, IL), Wilmot; John Glyndwr (Mount Airy, MD), Young; Matthew Egerton (Over Cambs, GB), Raven; Sophie Rebecca (Swavesey Cambs, GB), Murphy; Martin Joseph (Letchworth Garden City Hearts, GB), Hurlstone; Christopher John (Newport Saffron Walden Essex, GB), Daintrey; Joseph William (Royston Herts, GB), Rochford; Craig Malcolm (Monxton Andover Hants, GB), Kirkwood; Stephen Philip (Haynes Beds, GB), Mathews; Colin James (Godmanchester Huntingdon, GB), Hill; Robert L. (Abingdon, MD)
Assignee:	Meridian Medical Technologies, Inc. (Columbia, MD)
Application Number:	12/258,754
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,048,035
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 8,048,035

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Mylan Speciality Lp	EPIPEN	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-001	Dec 22, 1987	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Mylan Speciality Lp	EPIPEN JR.	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	019430-002	Dec 22, 1987	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,048,035

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,870,827	Automatic injector	➤ Sign Up
7,449,012	Automatic injector	➤ Sign Up
9,586,010	Automatic injector with needle cover	➤ Sign Up
7,794,432	Automatic injector with kickback attenuation	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,048,035

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2005271355	➤ Sign Up
Australia	2010201665	➤ Sign Up
Australia	2013222015	➤ Sign Up
Canada	2576776	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,048,035

For more information try a trial or see the plans and pricing